Development
NeuroOne Medical Technologies Corporation
NMTC
$0.5817
-$0.0073-1.24%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -50.94% | -18.60% | 10.38% | 18.07% | 17.33% |
| Total Depreciation and Amortization | 71.77% | 68.04% | 58.18% | 49.95% | 48.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.69% | 4.70% | 9.47% | -27.38% | -29.85% |
| Change in Net Operating Assets | -55.87% | -300.12% | 47.76% | -20.37% | -83.77% |
| Cash from Operations | -58.46% | -71.38% | 15.14% | 15.23% | 11.14% |
| Capital Expenditure | -81.93% | -39.57% | -60.88% | -39.95% | -75.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 201.94% | 201.92% | -- | -- | -- |
| Cash from Investing | 182.00% | 181.67% | -37.48% | -468.93% | -2,363.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -35.66% | -80.88% | -93.08% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6,735.00% | 19.26% | 82.64% | 86.76% | -101.46% |
| Cash from Financing | 53,973.75% | -38.46% | -81.60% | -94.63% | -100.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.75% | -325.41% | -697.46% | -681.00% | -227.18% |